Physician profile
Ashley Noone
NPI 1740727569
$13,976.19
in general payments reported to CMS, 2019-2025
27 companies · $2,603 in 2025
The $2,603 reported for 2025 was more than what 95% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $856 · 2022: $2,993 · 2023: $4,018 · 2024: $3,506 · 2025: $2,603.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,694 · Education: $433.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,694.27 |
| Education | $432.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,840.80 | 2021-2025 | |
| Janssen Biotech, INC. | $1,476.42 | 2021-2025 | Tremfya, Remicade, Simponi |
| Medimetriks Pharmaceuticals, INC. | $1,469.66 | 2022-2025 | Clindacin Etz, Neuac, Clodan |
| Dermavant Sciences, INC. | $912.82 | 2022-2024 | Vtama |
| Genzyme Corporation | $901.78 | 2021-2025 | |
| Galderma Laboratories, L.P. | $727.22 | 2021-2025 | Nemluvio, Aklief, Oracea |
| Ucb, INC. | $640.07 | 2022-2025 | Bimzelx, Cimzia |
| Journey Medical Corporation | $596.62 | 2022-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $553.22 | 2021-2025 | Cabtreo, Jublia |
| E.R. Squibb & Sons, L.L.C. | $444.79 | 2022-2025 | Sotyktu |
| Incyte Corporation | $382.28 | 2021-2025 | Opzelura |
| Sun Pharmaceutical Industries INC. | $370.25 | 2021-2024 | Winlevi, Blu-U, Odomzo |
| Amgen INC. | $359.67 | 2023-2025 | Otezla, Otezla |
| Lilly USA, LLC | $346.36 | 2021-2025 | Olumiant, Taltz, Ebglyss |
| Pfizer INC. | $285.15 | 2022-2023 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arcutis Biotherapeutics, INC. | $240.18 | 2023-2025 | Zoryve |
| Leo Pharma INC. | $239.56 | 2021-2025 | Anzupgo |
| Janssen Scientific Affairs, LLC | $224.99 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $220.91 | 2022-2025 | |
| Mayne Pharma Commercial LLC | $201.70 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $183.48 | 2022-2025 | Dupixent |
| Epi Health, LLC | $136.70 | 2022 | |
| Organon LLC | $112.37 | 2025 | Vtama |
| Vyne Pharmaceuticals INC. | $55.03 | 2021 | |
| Almirall LLC | $23.95 | 2021-2023 | Seysara |
| Botanix Sb INC | $17.55 | 2025 | Sofdra |
| Biofrontera INC. | $12.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Noone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.